Aclaris Therapeutics To Attend Upcoming Investor Conferences

MALVERN, Pa., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical-stage specialty pharmaceutical company, today announced that management will host investor meetings during:
  • Citi's 2016 Global Healthcare Conference in New York, NY on Thursday, December 8, 2016
  • Guggenheim's 2016 Annual Healthcare Conference in Boston, MA on Tuesday, December 13, 2016

About Aclaris Therapeutics, Inc.Aclaris Therapeutics, Inc. is a clinical-stage dermatologist-led pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology.  Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting Aclaris' website at www.aclaristx.com.

Contact:Aclaris ContactMichael Tung, M.D. Vice President / Investor Relations484-329-2140mtung@aclaristx.comMedia ContactMariann CaprinoTogoRun917-242-1087M.Caprino@togorun.com

Primary Logo

If you liked this article you might like

Skin Lesion Drug Only Scratches the Surface, Says Aclaris CEO

New Skin Lesion Drug Only Scratches Market's Surface, Says Aclaris CEO

5 Stocks With Big Insider Buying -- Should You Love Them Too?

5 Stocks Insiders Love Right Now

Jim Cramer's 'Mad Money' Recap: Watching China Warily, Again